2005
DOI: 10.1111/j.1365-2559.2005.02316.x
|View full text |Cite
|
Sign up to set email alerts
|

PEComa: what do we know so far?

Abstract: PEComas (tumours showing perivascular epithelioid cell differentiation) are a family of related mesenchymal neoplasms that include angiomyolipoma, lymphangiomyomatosis, clear cell "sugar" tumour of the lung, and a group of rare, morphologically and immunophenotypically similar lesions arising at a variety of visceral and soft tissue sites. These tumours all share a distinctive cell type, the perivascular epithelioid cell or "PEC' (which has no known normal tissue counterpart). PEComas show a marked female pred… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
329
2
3

Year Published

2007
2007
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 439 publications
(350 citation statements)
references
References 85 publications
(112 reference statements)
6
329
2
3
Order By: Relevance
“…These lesions are defined as "mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells". While the origin of these cells is unknown, PEComas include angiomyolipoma (AML), lymphangio-leiomyomatosis (LAM), clear cell 'sugar' tumor of the lung, clear cell myomelanocytic tumor of the falciform ligament, and other "unusual clear cell tumors" designated as PEComas not otherwise specified (NOS) 2 . Such tumors may be conceptualized as monotypic epithelioid or spindled non-renal AML, akin to the monotypic tumors known to occur in TSC-associated renal AML.…”
Section: Introductionmentioning
confidence: 99%
“…These lesions are defined as "mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells". While the origin of these cells is unknown, PEComas include angiomyolipoma (AML), lymphangio-leiomyomatosis (LAM), clear cell 'sugar' tumor of the lung, clear cell myomelanocytic tumor of the falciform ligament, and other "unusual clear cell tumors" designated as PEComas not otherwise specified (NOS) 2 . Such tumors may be conceptualized as monotypic epithelioid or spindled non-renal AML, akin to the monotypic tumors known to occur in TSC-associated renal AML.…”
Section: Introductionmentioning
confidence: 99%
“…11,12 PEComas, including LAM, exhibit evidence of mTOR activation, including increased phosphorylation of S6. 13 Given the neoplastic nature of the LAM lesion, and the evidence for constitutive activation of the mTOR pathway that controls glucose homeostasis, we postulated that the LAM lesion would exhibit increased metabolic uptake of [ 18 F]2-fluoro-2-deoxyglucose (FDG) detected by PET scanning.…”
mentioning
confidence: 99%
“…Based on the review by Hornick et al [6] PEComas (excluding renal AML, LAM, and CCST of lung) most commonly involve the retroperitoneal, visceral, abdominal, and pelvic sites. The gastrointestinal tract and the uterus are the most common extrarenal organs involved with soft tissue and skin being less frequently involved.…”
Section: Discussionmentioning
confidence: 99%
“…While the perivascular distribution of tumor cells is characteristic, it may not be seen in all PEComas, which most typically have a delicate vascular stroma surrounding tumor nests. Immunohistochemically, coexpression of melanocytic (HMB-45 and/or Melan-A) and myoid markers is characteristic [6]. The growing interest in PEComas has led to an increasing number of reports demonstrating different anatomic locations of these lesions, including several case reports involving various head and neck sites.…”
Section: Introductionmentioning
confidence: 99%